M Barančoková, D Kikelj, J Ilaš - Future medicinal chemistry, 2018 - Taylor & Francis
New antibacterials that modulate less explored targets are needed to fight the emerging bacterial resistance. DNA gyrase and topoisomerase IV are attractive targets in this search …
ASA Almalki, S Nazreen, AM Malebari, NM Ali… - Pharmaceuticals, 2021 - mdpi.com
A library of 1, 2, 3-triazole-incorporated thymol-1, 3, 4-oxadiazole derivatives (6–18) hasbeen synthesized and tested for anticancer and antimicrobial activities. Compounds 7, 8 …
DNA gyrase and topoisomerase IV (topo IV) inhibitors are among the most interesting antibacterial drug classes without antibacterial pipeline representative. Twenty-four new …
M Durcik, AE Cotman, Z Toplak, S Mozina… - Journal of medicinal …, 2023 - ACS Publications
A new series of dual low nanomolar benzothiazole inhibitors of bacterial DNA gyrase and topoisomerase IV were developed. The resulting compounds show excellent broad …
M S. Hifnawy, HM Hassan, R Mohammed, M M. Fouda… - Marine Drugs, 2020 - mdpi.com
Liquid chromatography coupled with high resolution mass spectrometry (LC-HRESMS)- assisted metabolomic profiling of two sponge-associated actinomycetes, Micromonospora …
Flavonoids are a class of bioactive plant-derived natural products that exhibit a broad range of biological activities, including antibacterial ones. Their inhibitory activity toward Gram …
A series of coumarin derivatives were designed, synthesized, and evaluated for their antiproliferative activity. Compound 3e exhibited significant antiproliferative activity and was …
New antibacterial drugs are urgently needed to tackle the rapid rise in multi-drug resistant bacteria. DNA gyrase is a validated target for the development of new antibacterial drugs …
A novel series of ciprofloxacin hybrids comprising various heterocycle derivatives has been synthesized and structurally elucidated using 1H NMR, 13C NMR, and elementary analyses …